We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Olympus America Acquires Bacus Labs

By Labmedica staff writers
Posted on 27 Jul 2006
Print article
Olympus America Inc. (Melville, NY, USA), a precision technology company that designs imaging systems for use in healthcare and life sciences, has acquired privately-owned Bacus Laboratories, Inc. (BLI, Lombard, IL, USA). BLI will retain its name, and all employees will retain their positions. Licenses and other business relationships will remain mostly unaffected. Financial details were not disclosed.

By securing BLI's patents and capabilities as part of the transaction, Olympus has gained access to two key technologies, virtual microscope slide and telemedicine, enabling the company to offer a one-step solution to companies seeking a virtual microscope slide system. Virtual slides allow professionals to review biopsies and other pathology images without handling traditional glass slides. Using telemedicine, doctors can share highly detailed microscope slide images over the internet for long-distance consultation.

Among the products to be sold by the combined company is the Bliss system, designed for a single workstation, which is a combination of an Olympus microscope with BLI software. BLI also provides virtual microscope slides and internet software for medical education.

More than 60% of professional decisions made by physicians are influenced by medical testing. Medical slides contain so much high-resolution data that it can take thousands of typical digital pictures to reproduce all the data in one image, and require powerful computers to store the data. The combination of Olympus and BLI technologies can help streamline the process, save substantial expense, and enhance patient care.

Dr, Stephen S. Tang, group vice president and general manager of Life Science, Olympus America, said "Being able to digitize slides and share analysis, and attach images to a patient's file is the step we have been waiting for. It paves the way to more informed decisions by physicians, better-served patients, and enhanced teaching and training.”





Related Links:
Olympus America
Bacus Laboratories
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Hepatitis B Virus Test
HBs Ab – ELISA
New
PSA Test
Human Semen Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.